Financial Analysis: Fly Leasing (FLY) and Avant Diagnostics (AVDX)

Fly Leasing (NYSE:FLY) and Avant Diagnostics (OTCMKTS:AVDX) are both small-cap transportation companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends and profitability.

Analyst Ratings

This is a summary of current ratings and price targets for Fly Leasing and Avant Diagnostics, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fly Leasing 2 0 1 0 1.67
Avant Diagnostics 0 0 0 0 N/A

Fly Leasing presently has a consensus target price of $19.83, suggesting a potential upside of 62.04%. Given Fly Leasing’s higher possible upside, equities research analysts clearly believe Fly Leasing is more favorable than Avant Diagnostics.

Earnings & Valuation

This table compares Fly Leasing and Avant Diagnostics’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fly Leasing $353.25 million 0.99 $2.59 million $0.09 136.00
Avant Diagnostics $110,000.00 33.70 -$11.75 million N/A N/A

Fly Leasing has higher revenue and earnings than Avant Diagnostics.


This table compares Fly Leasing and Avant Diagnostics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Fly Leasing 15.32% 11.41% 1.80%
Avant Diagnostics N/A N/A N/A

Risk and Volatility

Fly Leasing has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Comparatively, Avant Diagnostics has a beta of 3.28, meaning that its share price is 228% more volatile than the S&P 500.

Institutional and Insider Ownership

50.3% of Fly Leasing shares are held by institutional investors. Comparatively, 0.0% of Avant Diagnostics shares are held by institutional investors. 38.0% of Avant Diagnostics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.


Fly Leasing beats Avant Diagnostics on 8 of the 11 factors compared between the two stocks.

About Fly Leasing

Fly Leasing Limited, through its subsidiaries, purchases and leases commercial aircrafts under multi-year contracts to various airlines worldwide. As of December 31, 2017, the company had a portfolio of 85 aircrafts, including 73 narrow-body passenger aircrafts and 12 wide-body passenger aircrafts. Fly Leasing Limited was founded in 2007 and is headquartered in Dún Laoghaire, Ireland.

About Avant Diagnostics

Avant Diagnostics, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary diagnostic tests that provide information for physicians and patients in the areas of cancers. It offers OvaDx, a noninvasive proteomics diagnostic screening test for the early detection of ovarian cancer; and MSPrecise, a DNA sequencing assay for the identification of patients with relapsing-remitting multiple sclerosis at first clinical presentation. The company is based in Washington, District of Columbia.

Receive News & Ratings for Fly Leasing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fly Leasing and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit